PRESS RELEASE:
The Fourth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum Features Nation's Leading Pharmaceutical Sector Regulators and Compliance Professionals
  • Sponsored by Pharmaceutical Compliance Forum
  • November 12 - 14, 2003
  • Renaissance Marriott Hotel, Washington, DC
  • www.PharmaCongress.com
PRESS RELEASE
Contact: Paul Tunnecliff
800-684-4549 phone
registration@hcconferences.com

WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICE(TM) -- JULY 30, 2003: The Pharmaceutical Compliance Forum, the leading association of pharmaceutical industry compliance professionals, announced today the scheduling of its Fourth Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum, which will be held November 12 - 14, 2003, in Washington, DC. See www.PharmaCongress.com.

SPONSOR: THE PHARMACEUTICAL COMPLIANCE FORUM:

The Congress is sponsored by the Pharmaceutical Compliance Forum (PCF). PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry, to promote effective corporate compliance programs. The organization is open to others in the industry, and has more than doubled its membership since it was founded. The members meet twice a year, for 1-2 days, focusing on open and informal sharing of compliance information, best practices and current developments in the field.

KEYNOTE SPEAKERS:

Raymond Gilmartin
Chairman, President and CEO
Merck & Co., Inc.
Whitehouse Station, NJ


Mark B. McClellan, MD, Ph.D.
Commissioner of Food and Drugs
Food and Drug Administration
Rockville, MD


Dennis Nally
Chairman and Senior Partner
PricewaterhouseCoopers
New York, NY


Thomas Scully
Administrator, Center for Medicare and Medicaid Services
Department of Health and Human Services
Washington, DC

FEATURED FACULTY:

Thomas Abrams
Director, Division of Drug Advertising
Marketing & Communications
U.S. Food and Drug Administration
Rockville, MD


Joan Antokol
Chief Privacy Officer, Novartis
East Hanover, NJ


John Bentivoglio, Esq.
Partner, Arnold and Porter
and Former Special Counsel for Healthcare Fraud
Chief Privacy Officer, United States Department of Justice
Washington, DC


Cindy Chen, Esq.
Counsel, Pfizer Inc
New York, NY


John Clay
Senior Adviser, E-Business
North American Commercial Operations
Aventis Pharmaceuticals
Bridgewater, NJ


Stanley W. Crosley Esq.
Chief Privacy Officer
Eli Lilly and Company (Law Division)
Lilly Corporate Center
Indianapolis, IN


Sujata T. Dayal Esq.
Counsel, Domestic Legal Operations
Abbott Laboratories
Abbott Park, IL


Allison J. Gassaro Esq.
Senior Attorney - NA Legal
Aventis Pharmaceuticals
Bridgewater, NJ


John Guthrie, Esq.
Director, Medicaid Fraud Control Unit
Office of Attorney General
Columbus, OH


Peter Barton Hutt, Esq.
Partner, Covington & Burling
and Former Chief Counsel, Food and Drug Administration
Washington, DC


Oliver Johnson
Chief Privacy Officer, Merck
Whitehouse Station, NJ


Paul Kalb, MD, JD
Partner, Sidley Austin Brown & Wood
Washington, DC


Mark Allen Kleiman, Esq.
Partner , Law Offices of Mark Allen Kleiman
Los Angeles, CA


Stan Krosley
Chief Privacy Officer, Eli Lily

Douglas Lankler, Esq.
Corporate Counsel, Compliance
Pfizer, Inc.
New York, NY


Thomas B. Leary, Esq.
Commissioner, Federal Trade Commission
Washington, DC


Arthur Levine, Esq.
Partner, Arnold & Porter
and Former Deputy Chief Counsel for Litigation
Food and Drug Administration
Washington, DC


Robert S. Litt, Esq.
Partner, Arnold & Porter
and Former Principal Associate Deputy Attorney General
United States Department of Justice
Washington, DC


Michael Loucks, Esq.
Chief of the Health Care Fraud Unit
Assistant U.S. Attorney
U.S. Attorney's Office for the District of Massachusetts
Boston, MA


Justin McCarthy Esq.
Assistant General Counsel, Global Research and Development
Pfizer, Inc.
New London, CT


Stephen Meagher, Esq.
Partner, Phillips & Cohen
San Francisco, CA


Lewis Morris, Esq.
General Counsel
Office Of Inspector General
Department of Health and Human Services
Washington, DC


Arjun Rajaratnam, Esq.
Compliance Officer, Global Pharmaceuticals
GlaxoSmithKline
Research Triangle Park, NC


Brenton Saunders, JD, MBA
Partner, PricewaterhouseCoopers
Past President, Health Care Compliance Association
Founder and Chair-elect
International Association of Privacy Officers
Washington, DC


James Sheehan, Esq.
Chief of the Civil Division
Assistant U.S. Attorney
U.S. Attorney's Office for the Eastern District of Pennsylvania
Philadelphia, PA


Dalton Smart
Director, International Compliance
Schering-Plough Corporation
Kenilworth, NJ


Jonathan A. Smollen
Chief Privacy Officer
Wyeth Pharmaceuticals
St. Davids, PA


Bert Spilker, PhD, MD, FCP, FFPM
President, Bert Spilker & Associates
Clinical Professor, Pharmacy Practice, University of Minnesota
and Former, Senior Vice President of Scientific
and Regulatory Affairs, PhRMA
Bethesda, MD


Paul A. Sundberg Esq.
Staff Counsel, Commercial Legal Operations
Takeda Pharmaceuticals North America, Inc.
Lincolnshire, IL


Bert Weinstein, Esq.
Vice President and Assistant General Counsel
Merck & Co.
Whitehouse Station, NJ


Janice Whitaker
Senior Vice President, Quality Assurance
GlaxoSmithKline


Janet Woodcock, MD
Director, Center for Drug Evaluation and Research
Food and Drug Administration
Rockville, MD

EXHIBIT & SPONSORSHIP INFORMATION:

For sponsorship and exhibit information review the Promotional Opportunities pages on the Congress website: http://www.PharmaCongress.com or contact:

REGISTRATION INFORMATION:

For further registration info, call 800-684-4549, email: registration@hcconferences.com, or write:
    Pharma Congress Office
    7790 Barberry Ave.
    Yucca Valley, CA USA 92284
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS:

Please email your request to: webmaster@PharmaCongress.com.